BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23443776)

  • 21. Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2.
    Jiang T; Kuhen KL; Wolff K; Yin H; Bieza K; Caldwell J; Bursulaya B; Tuntland T; Zhang K; Karanewsky D; He Y
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2109-12. PubMed ID: 16464578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of novel MKC-442 analogues with potent activities against HIV-1.
    El-Brollosy NR; Pedersen EB; Nielsen C
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):236-41. PubMed ID: 12916058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.
    Li X; Zhan P; Liu H; Li D; Wang L; Chen X; Liu H; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Bioorg Med Chem; 2012 Sep; 20(18):5527-36. PubMed ID: 22883027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibitory effect of polysaccharides on the six-alpha-helix bundle formation of HIV gp41 protein].
    Wen XY; Wu SY; Xu W; Lv L; Liu SW; Rao JJ; Zhang JJ; Wang GF; Wan SH; Wu SG
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1498-500. PubMed ID: 17959523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput screening method of inhibitors that block the interaction between 2 helical regions of HIV-1 gp41.
    Jin BS; Lee WK; Ahn K; Lee MK; Yu YG
    J Biomol Screen; 2005 Feb; 10(1):13-9. PubMed ID: 15695339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.
    Kazmierski WM; Kenakin TP; Gudmundsson KS
    Chem Biol Drug Des; 2006 Jan; 67(1):13-26. PubMed ID: 16492145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationship study of pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives for potent anti-HIV agents.
    Mizuhara T; Oishi S; Ohno H; Shimura K; Matsuoka M; Fujii N
    Bioorg Med Chem; 2012 Nov; 20(21):6434-41. PubMed ID: 23022280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.
    Kim J; Kwon J; Lee D; Jo S; Park DS; Choi J; Park E; Hwang JY; Ko Y; Choi I; Ju MK; Ahn J; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Ahn S; Sommer P; Liuzzi M; No Z; Lee J
    Bioorg Med Chem Lett; 2013 Jan; 23(1):153-7. PubMed ID: 23206860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of new mononucleotide prodrugs: aryl (SATE) phosphotriester derivatives.
    Peyrottes S; Schlienger N; Beltran T; Lefebvre I; Pompon A; Gosselin G; Aubertin AM; Imbach JL; Périgaud C
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):315-21. PubMed ID: 11563043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
    Fattorusso C; Gemma S; Butini S; Huleatt P; Catalanotti B; Persico M; De Angelis M; Fiorini I; Nacci V; Ramunno A; Rodriquez M; Greco G; Novellino E; Bergamini A; Marini S; Coletta M; Maga G; Spadari S; Campiani G
    J Med Chem; 2005 Nov; 48(23):7153-65. PubMed ID: 16279773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of 3,4-dihydropyrimidin-2(1H)-ones with inhibitory activity against HIV-1 replication.
    Kim J; Park C; Ok T; So W; Jo M; Seo M; Kim Y; Sohn JH; Park Y; Ju MK; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Sommer P; No Z
    Bioorg Med Chem Lett; 2012 Mar; 22(5):2119-24. PubMed ID: 22305583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds.
    Venkatachalam TK; Mao C; Uckun FM
    Bioorg Med Chem; 2004 Aug; 12(15):4275-84. PubMed ID: 15246104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6-aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays.
    Costi R; Di Santo R; Artico M; Roux A; Ragno R; Massa S; Tramontano E; La Colla M; Loddo R; Marongiu ME; Pani A; La Colla P
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1745-9. PubMed ID: 15026063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening of HIV-1 replication inhibitors by using pseudotyped virus system].
    Cao YL; Guo Y
    Yao Xue Xue Bao; 2008 Mar; 43(3):253-8. PubMed ID: 18630260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-nucleoside reverse transcriptase inhibitors (Part 18): synthesis and anti-HIV activity of 4-allylamino or 4-azido substituted diaryltriazines.
    Xiong YZ; Hu HR; Chen FE; Balzarini J; Pannecouque C; de Clercq E
    Yao Xue Xue Bao; 2009 Feb; 44(2):145-9. PubMed ID: 19408683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
    Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.
    Zhan P; Liu X; Fang Z; Pannecouque C; De Clercq E
    Bioorg Med Chem; 2009 Sep; 17(17):6374-9. PubMed ID: 19647440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro.
    Long J; Zhang DH; Zhang GH; Rao ZK; Wang YH; Tam SC; He YP; Zheng YT
    Yao Xue Xue Bao; 2010 Feb; 45(2):228-34. PubMed ID: 21348416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.